VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 251 filers reported holding VAXCYTE INC in Q1 2024. The put-call ratio across all filers is 0.73 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $98,951,022 | +3.7% | 1,310,436 | -6.2% | 0.48% | +1.7% |
| Q1 2024 | $95,409,328 | -9.0% | 1,396,711 | -16.4% | 0.47% | -16.4% |
| Q4 2023 | $104,887,869 | -1.7% | 1,670,189 | -20.2% | 0.57% | -7.7% |
| Q3 2023 | $106,716,689 | -9.9% | 2,093,305 | -11.7% | 0.61% | +1.3% |
| Q2 2023 | $118,418,627 | +274.0% | 2,371,218 | +180.7% | 0.60% | +258.0% |
| Q1 2023 | $31,662,279 | -24.7% | 844,778 | -3.7% | 0.17% | -25.9% |
| Q4 2022 | $42,066,199 | +17877.0% | 877,293 | +8965.8% | 0.23% | +22700.0% |
| Q1 2022 | $234,000 | – | 9,677 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 793,036 | $59,882,148 | 46.04% |
| Darwin Global Management, Ltd. | 2,080,946 | $163,916,116 | 19.07% |
| RA Capital Management | 8,203,754 | $619,465,465 | 8.19% |
| ACUTA CAPITAL PARTNERS, LLC | 110,400 | $8,336,304 | 7.02% |
| COMMODORE CAPITAL LP | 1,305,000 | $98,540,550 | 6.73% |
| Saturn V Capital Management LP | 215,680 | $16,285,997 | 6.15% |
| Cormorant Asset Management, LP | 1,100,000 | $83,061,000 | 4.80% |
| Kynam Capital Management, LP | 753,240 | $56,877,152 | 4.39% |
| Novo Holdings A/S | 950,000 | $71,734,500 | 4.16% |
| Frazier Life Sciences Management, L.P. | 1,039,405 | $78,485,472 | 3.67% |